Achieve Life Sciences, Inc. Restricted Cash and Cash Equivalents, Noncurrent
Achieve Life Sciences, Inc. (ACHV) had Restricted Cash and Cash Equivalents, Noncurrent of $50.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2021-03-11
- 2020-12-31: Restricted Cash and Cash Equivalents, Noncurrent $50.00K.
- 2020-09-30: Restricted Cash and Cash Equivalents, Noncurrent $50.00K.
- 2020-06-30: Restricted Cash and Cash Equivalents, Noncurrent $50.00K.
- 2020-03-31: Restricted Cash and Cash Equivalents, Noncurrent $50.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2020-12-31 | $50.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $50.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $50.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $50.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $50.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $50.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $50.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $50.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $50.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $50.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $50.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $50.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $50.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $272.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $272.00K 10-Q · filed 2017-07-31 |
| 2017-03-31 | $272.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $272.00K 10-Q · filed 2017-07-31 |
| 2016-09-30 | $272.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $272.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $272.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $272.00K 10-K · filed 2017-02-23 |
| 2015-09-30 | $222.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $190.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $190.00K 10-Q · filed 2015-05-14 |
| 2014-09-30 | $251.00K 10-Q · filed 2014-10-30 |
| 2014-06-30 | $251.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $251.00K 10-Q · filed 2014-04-30 |
| 2013-12-31 | $314.00K 10-K · filed 2015-03-26 |
| 2013-09-30 | $314.00K 10-Q · filed 2013-11-07 |
| 2012-12-31 | $314.00K 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |